tirzepatide effect on liver Can Zepbound (tirzepatide) be approved for weight loss in a patient with stage 1 hypertension, hypercalcemia, elevated enzymes, and dyslipidemia? Tirzepatide: A Game-Changer for MASH

PIONEER clinical trials series: Similar to the SUSTAIN series, the PIONEER trials focus on the oral formulation of semaglutide, contributing to the body of evidence supporting its use in clinical practice

Their success rate with stretch marks leads only to fading and not complete removal.

Evidence in Action: What Research Shows Frontiers in Endocrinology reports that GLP-1 receptor agonists influence appetite, glucose regulation, and energy balance through multiple central and peripheral pathways

The SUSTAIN 6 cardiovascular outcomes trial demonstrated that semaglutide significantly reduced the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes at high cardiovascular risk, many of whom were taking metformin as background therapy